Who Owns First Tracks Biotherapeutics Stock?
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 100.76%
- Institutions (% of float)
- 110.42%
- Held by insiders
- 8.75%
- Institutional holders
- 218
- Institutions 91.3%
- Insiders 8.7%
- Public and other 0.0%
Who owns First Tracks Biotherapeutics stock?
Institutional investors own about 100.8% of First Tracks Biotherapeutics's shares, spread across 218 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 8.75% of TRAX.
The largest institutional holders are EcoR1 Capital, LLC (8.88%), TCG Crossover Management, LLC (8.10%) and FMR, LLC (5.75%). Together, the top 10 institutions control 52.3% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their TRAX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TRAX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| EcoR1 Capital, LLC | 3.17M | 8.88% | +100.0% |
| TCG Crossover Management, LLC | 2.90M | 8.10% | +100.0% |
| FMR, LLC | 2.05M | 5.75% | +100.0% |
| Affinity Asset Advisors, Llc | 2.03M | 5.69% | +100.0% |
| Blackrock Inc. | 1.96M | 5.50% | +100.0% |
| Trails Edge Capital Partners, LP | 1.51M | 4.24% | +100.0% |
| State Street Corporation | 1.51M | 4.23% | +100.0% |
| Vanguard Capital Management LLC | 1.45M | 4.06% | +100.0% |
| Jupiter Topco LLC | 1.09M | 3.05% | +100.0% |
| Vestal Point Capital, LP | 1.01M | 2.84% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TRAX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.11M | 3.11% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 982.14K | 2.75% |
| iShares Trust-iShares Russell 2000 ETF | 598.85K | 1.68% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 400.00K | 1.12% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 309.29K | 0.87% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 290.00K | 0.81% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 255.15K | 0.71% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 217.75K | 0.61% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 200.00K | 0.56% |
| Victory Portfolios III-Victory Science & Technology Fund | 187.89K | 0.53% |
Frequently asked questions
Who is the largest shareholder of First Tracks Biotherapeutics?
EcoR1 Capital, LLC is the largest institutional shareholder of TRAX, owning 8.88% of shares outstanding (3.17M shares) as of its latest 13F filing.
What percentage of First Tracks Biotherapeutics is owned by institutions?
Institutions own about 100.8% of TRAX shares and 110.4% of the public float.
How much of First Tracks Biotherapeutics do insiders own?
Insiders, such as officers and directors, own about 8.75% of TRAX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.